|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |||
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. | SEC 1474 (9-02) |
1. Title of Derivative Security (Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) |
6. Date Exercisable and Expiration Date (Month/Day/Year) |
7. Title and Amount of Underlying Securities (Instr. 3 and 4) |
8. Price of Derivative Security (Instr. 5) |
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr. 4) |
||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Non-qualified Stock Options (3) | $ 64.42 | 02/12/2019 | M | 3,700 | 05/06/2010(4) | 05/06/2019 | Common Stock | 3,700 | $ 0 | 0 | D | ||||
Restricted Stock Unit | (1) | 02/12/2019 | M | 1,038 | (5) | (5) | Common Stock | 1,038 | $ 0 | 3,279 (6) (7) | D | ||||
Restricted Stock Unit | (1) | 02/12/2019 | A | 1,227 | (8) | (8) | Common Stock | 1,227 | $ 0 | 4,506 (6) (7) | D |
Reporting Owner Name / Address | Relationships | |||
Director | 10% Owner | Officer | Other | |
BELINGARD JEAN-LUC 531 SOUTH SPRING STREET BURLINGTON, NC 27215 |
X |
/s/ Sandra D. van der Vaart, Attorney-in-Fact for Jean-Luc Belingard | 02/14/2019 | |
**Signature of Reporting Person | Date |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
(1) | Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. |
(2) | Stock withholding to satisfy tax withholding obligations. |
(3) | Director stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan. |
(4) | The option vested in three equal annual installments beginning on the date reflected in this column and is now fully exercisable. |
(5) | The Restricted Stock Units vested fully on February 12, 2019. |
(6) | This number reflects the aggregate number of Restricted Stock Units held by the reporting person. |
(7) | Amount includes 105 Restricted Stock Units that were inadvertently omitted from the reporting person's original Form 4 filed on December 7, 2018, due to a clerical error. |
(8) | The Restricted Stock Units vest fully on February 12, 2020. |